Pharmacist Can Positively Influence Mpox Vaccinations

Once again, research affirms that healthcare professionals remain the most trusted source of information (73%) and can significantly influence disease prevention efforts, such as vaccination.

A University of Texas Southwestern Medical Center survey published on April 24, 2025, found that 58% of adults say they would be willing to be vaccinated against mpox if their healthcare provider recommended it.

This data represents a 12% increase since 2022.

According to an article published in Vaccine (Volume 56, May 22, 2025, 127141), self-reported knowledge of mpox (40%), as well as perceived self-efficacy (55%) and mean risk perception (3.2), have also increased since the 2022 survey.

Respondents from the Health and Human Services Region 1 (CT, ME, MA, NH, RI, VT) were the least likely to receive the vaccine, even when recommended to do so.

These results highlight the need for ongoing education among adults to improve awareness of and vaccination intention for the mpox vaccine.

The consistently high degrees of trust placed in healthcare professionals and officials should guide future communications about mpox and other infectious diseases, and reinforce the importance of leveraging trusted sources to share essential public health information, wrote these researchers.

In May 2022, an unprecedented global outbreak of mpox Clade IIb prompted the World Health Organization (WHO) to declare a Public Health Emergency of International Concern. Since then, mpox cases, including Clade 1, have been reported in more than 126 WHO Member States.

As of April 28, 2025, mpox vaccination (JYNNEOS) services are commercially offered throughout the United States.